EGFR and metastatic colorectal cancer: KRAS/NRAS/BRAFV600E/MSI for chemotherapy-naive metastatic colorectal cancer when tissue not available or urgent therapeutic decision making.KRAS/NRAS/BRAF/EGFR-ECD for pretreated patients if EGFR rechallenge is planned